In addition, several studies concur to indicate that higher ADO levels are observed in diabetics either because of a lesser ENT-1 expression, the physiologically most relevant equilibrative nucleoside transporter characterized by its massive ADO mobilization (Pawelczyk et al., 2003). The gene discussed is SLC29A1; the disease is diabetes mellitus.